HI homepage

MIT cancer ultrasound
Portable ultrasound helps novice users accurately perform breast exams

Experts from MIT, where the technology was developed, are optimistic their system can be used by almost anyone, including individuals with no ultrasound experience.  

Vandy docs first to successfully complete breast cancer surgery using intraoperative PET/CT
Vanderbilt docs 1st to use new PET imaging technique during breast cancer surgery

Once surgeons remove tumors, they use the scanner to determine whether the excised tissue is malignant, negating the need for additional pathology and enabling surgeons to precisely assess margins in real-time.

Thumbnail
Simpler lung cancer screening criteria could capture more patients likely to benefit

New research published in JAMA Internal Medicine compared current USPSTF criteria to a potential shift toward total years smoked, rather than pack years. 

artificial intelligence
Nearly 100% of patients surveyed say they’d want to know when AI is used in imaging

Researchers recently sought to better understand how patients perceive rapidly evolving advancements in AI, sharing their findings in RSNA’s Radiology

the words "FDA recall" on a board
Servers recalled after glitch results in radiologists reading images for wrong patients

The issue could cause a reader to unintentionally report on the wrong patient when using interactive applications, according to a notice from the FDA. 

Siemens Healthineers CEM and biopsy features cleared by FDA
FDA clears contrast-enhanced mammography, biopsy features for breast imaging system

Interest in CEM has seen significant growth in recent years as more clinical evidence supporting its use has come to light. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.